HighVista Strategies’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.2M Sell
421,881
-123,198
-23% -$1.1M 1.16% 17
2025
Q4
$4.61M Buy
545,079
+304,620
+127% +$2.17M 1.19% 24
2025
Q3
$1.26M Buy
240,459
+90,758
+61% +$346K 0.31% 104
2025
Q2
$518K Buy
+149,701
New +$445K 0.19% 125
2023
Q3
Sell
-32,197
Closed -$404K 159
2023
Q2
$404K Sell
32,197
-97,048
-75% -$1.21M 0.19% 123
2023
Q1
$2.13M Sell
129,245
-47,276
-27% -$848K 1.73% 21
2022
Q4
$2.64M Buy
176,521
+9,138
+5% +$175K 1.57% 18
2022
Q3
$3.74M Buy
167,383
+54,070
+48% +$1.19M 2.14% 9
2022
Q2
$1.9M Buy
113,313
+44,705
+65% +$958K 1.15% 28
2022
Q1
$2.05M Buy
68,608
+22,616
+49% +$549K 1.31% 21
2021
Q4
$1.41M Buy
45,992
+8,249
+22% +$261K 1.12% 25
2021
Q3
$1.19M Buy
37,743
+14,493
+62% +$488K 0.79% 38
2021
Q2
$851K Buy
23,250
+6,374
+38% +$210K 0.6% 34
2021
Q1
$583K Buy
16,876
+1,901
+13% +$82.5K 0.43% 61
2020
Q4
$622K Buy
+14,975
New +$677K 0.4% 63

Other funds holding RLAY